MetLife Investment Management’s Shattuck Labs STTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,596
Closed -$85.8K 2856
2024
Q3
$85.8K Buy
24,596
+13,859
+129% +$51.7K ﹤0.01% 2685
2024
Q2
$41.4K Buy
+10,737
New +$87.3K ﹤0.01% 2787
2021
Q4
Sell
-10,943
Closed -$223K 2550
2021
Q3
$223K Hold
10,943
﹤0.01% 2021
2021
Q2
$317K Buy
10,943
+4,758
+77% +$139K ﹤0.01% 1849
2021
Q1
$181K Hold
6,185
﹤0.01% 2108
2020
Q4
$324K Buy
+6,185
New +$199K ﹤0.01% 1715

Other funds holding STTK

MetLife Investment Management's STTK Position: Q4 2024 in Review

MetLife Investment Management sold out of Shattuck Labs (STTK) in Q4 2024, closing a stake of 24,596 shares — an estimated $85.8K sold.

MetLife Investment Management first reported a position in STTK in Q4 2020 and held it in 6 quarters. The position peaked at $324K in Q4 2020. 75 funds tracked by Wall St. Rank hold STTK as of Q4 2024.

  • MetLife Investment Management reported no remaining Shattuck Labs position as of Q4 2024 after selling out during the quarter.
  • MetLife Investment Management sold 24,596 Shattuck Labs shares in Q4 2024, an estimated $85.8K.
  • MetLife Investment Management first reported a position in Shattuck Labs in Q4 2020 and held it in 6 quarters.
  • MetLife Investment Management's Shattuck Labs position peaked at $324K in Q4 2020.
  • 75 funds tracked by Wall St. Rank held Shattuck Labs as of Q4 2024.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.